AI
Alphabet Inc’s Lyell Immunopharma LYEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.59M | Sell |
293,256
-5,571,869
| -95% | -$49.3M | 0.12% | 21 |
|
2025
Q1 | $3.17M | Hold |
5,865,125
| – | – | 0.2% | 23 |
|
2024
Q4 | $3.75M | Hold |
5,865,125
| – | – | 0.22% | 19 |
|
2024
Q3 | $8.09M | Hold |
5,865,125
| – | – | 0.44% | 17 |
|
2024
Q2 | $8.5M | Hold |
5,865,125
| – | – | 0.43% | 16 |
|
2024
Q1 | $13.1M | Hold |
5,865,125
| – | – | 0.52% | 14 |
|
2023
Q4 | $11.4M | Hold |
5,865,125
| – | – | 0.53% | 17 |
|
2023
Q3 | $8.62M | Hold |
5,865,125
| – | – | 0.55% | 18 |
|
2023
Q2 | $18.7M | Hold |
5,865,125
| – | – | 1% | 16 |
|
2023
Q1 | $13.8M | Hold |
5,865,125
| – | – | 0.77% | 19 |
|
2022
Q4 | $20.4M | Hold |
5,865,125
| – | – | 1.18% | 17 |
|
2022
Q3 | $43M | Hold |
5,865,125
| – | – | 2.2% | 12 |
|
2022
Q2 | $38.2M | Hold |
5,865,125
| – | – | 2.08% | 12 |
|
2022
Q1 | $29.6M | Hold |
5,865,125
| – | – | 0.96% | 17 |
|
2021
Q4 | $45.4M | Hold |
5,865,125
| – | – | 1.1% | 16 |
|
2021
Q3 | $86.8M | Hold |
5,865,125
| – | – | 2.06% | 11 |
|
2021
Q2 | $95.3M | Buy |
+5,865,125
| New | +$95.3M | 1.94% | 8 |
|